by Admin | Jan 14, 2022 | News & Opinions
By Karen Weintraub – January 10, 2022 – APNews.com (link to article) A Maryland man has lived for three days with a pig heart beating inside his chest. The surgery, at the University of Maryland Medical Center, marks the first time a gene-edited pig has...
by Admin | Jan 13, 2022 | News & Opinions
By Alex Keown – Jan 10, 2022 – biospace.com (link to article) Bayer and Mammoth Biosciences forged a strategic collaboration potentially valued at more than $1 billion. The partnership grants the Germany-based pharma giant access to Mammoth’s CRISPR...
by Admin | Jan 12, 2022 | News & Opinions
By: ALLISON GATLIN – Investors.com – 01/10/2022 (link to article) Pfizer (PFE) is entering the CRISPR space through a $1.35 billion deal with Beam Therapeutics (BEAM), the companies announced Monday. But Beam stock fell on the deal. Beam is using CRISPR...
by Admin | Dec 24, 2021 | News & Opinions
As 2021 draws to a close, we celebrate the first decade of STEM CELLS Translational Medicine (SCTM) with gratitude to our devoted editors, reviewers, authors, and of course, our global loyal readership … all of you are a vital part of this first decade’s...
by Admin | Dec 8, 2021 | News & Opinions
by Margarida Maia, PhD Repeat injections of mesenchymal stem cells (MSCs) into the spinal canal were safe and well tolerated in patients with amyotrophic lateral sclerosis (ALS), and showed potential to significantly slow the rate of disease progression, a small Phase...
